Press release
Stratophase Successfully Completes Bio-Detection Project
Portable optical microchip technology accurately detects Foot and Mouth Disease in laboratory testsStratophase, a specialist in real-time chemical and biochemical measurement, has announced the successful completion of the Portable Direct Immunoassay Diagnosis Devices for Animals and Humans (PDIDDAH) project. Using Stratophase’s proprietary optical microchip technology, the goal of the proof-of-principle study was to assess the feasibility of using a self-contained, portable detection unit to accurately identify the presence of Foot and Mouth Disease (FMD). The £1 million project, co-funded by the UK government-sponsored Technology Strategy Board, was performed in collaboration with the Institute of Biotechnology (University of Cambridge), Bristol Industrial and Research Associates Limited and the Chelsea Technologies Group. When testing the prototype in a laboratory environment, the unit was able to detect FMD quickly, easily and with a high degree of accuracy. If further developed, such a device would allow veterinary professionals, inspectors and farmers to make rapid, informed decisions at the site of infection during disease outbreaks, avoiding the need to cull of healthy livestock.
To address this need, Stratophase has developed a transportable FMD detection unit utilising the company’s proprietary optical microchip technology, which measures changes in refractive index (RI) at the surface of an optical chip. During analysis, the sample is mixed with a liquid and pumped across the chip surface, where any FMD viral particles present bind to specific receptor molecules, altering the local RI and leading to positive detection. The chips themselves are incorporated into low cost, disposable cartridges, which are inserted into the detection unit during testing. The research carried out as part of the PDIDDAH project has successfully shown that the platform has the potential to provide a robust, rapid, accurate, easy-to-use solution for the on-site detection of FMD.
On completion of the project, Richard Williams, Stratophase’s chief executive, said, “We are delighted with the results of the PDIDDAH collaboration and believe it provides the perfect basis for further developing our bio-detection technology. As well as a clear application in veterinary diagnostics, our optical microchips can be configured to detect a whole range of biological agents, making them ideal for on-site testing in environments as diverse as battlefields, hospitals and farms.” The success of the project has showcased what can be achieved using Stratophase’s technology, and the company expects to commercialise its portable detection solution for veterinary diagnostics in the future through collaboration with strategic partners already active in the field.
To find out more, visit the new Stratophase website at www.stratophase.com.
About Stratophase:
Stratophase is a VC-funded spin-out from the University of Southampton in the UK. Its unique technology is an optical microchip sensor which measures chemical processes and detects biological targets. This core optical measurement technology can be realised in a vast array of sensing heads, offering a wide variety of system configurations applicable to a broad spectrum of industries including chemical and biochemical production as well as biological detection.
The Stratophase team, guided by CEO Dr Richard Williams, includes the original inventors of the SpectroSens technology as well as senior managers with a vast array of industry experience.
Alto Marketing
Office 3 Universal Marina | Crableck Lane | Sarisbury Green | Southampton | SO31 7AL | UK
Product Enquiries
Stratophase
Sam Watts – Business Development & Commercial Officer
t: +44 (0)1794 511226
e: sam.watts@stratophase.com
Media enquiries
Alto Marketing Limited
Paul Avery – Science Writer
t: +44 (0)1489 557672
e: paula@alto-marketing.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stratophase Successfully Completes Bio-Detection Project here
News-ID: 180235 • Views: …
More Releases from Stratophase
Stratophase Presents Solution for Multiplexed Detection of Biological Agents at …
Stratophase, innovators in real-time in situ monitoring and diagnostics, will be presenting a talk entitled “Optical microchip sensors for multiplexed detection of biological agents” at this year’s Bio-Sensing conference in Amsterdam, the Netherlands, 10-12 October. The presentation by Devaki Bhatta, Stratophase’s Head of Biodetection, will outline the latest developments in bio-detection solutions utilising the company’s proprietary SpectroSens™ optical microchip technology.
By using light to measure change, Stratophase’s unique technology brings…
Stratophase to Exhibit at BioTechnica 2011
SpectroSens™ Technology for Real-time Monitoring and Diagnostics to be showcased at Stand A28, Hall 9
Stratophase, innovators in real-time in situ monitoring and diagnostics, will be exhibiting and showcasing its unique SpectroSens™ optical microchip technology at Biotechnica 2011 (11th – 13th October). SpectroSens draws on Stratophase’s expertise in fibre optic communications and solid state silicon device manufacture to create a powerful sensing tool for real-time, in-line monitoring and portable biological detection.…
Optical Biodetector Successfully Detects Anthrax and Ricin Toxin in Tests
Stratophase’s technology demonstrated for label-free detection of biothreat agents as part of MoD-funded project
Stratophase, a specialist in real-time chemical and biochemical measurement, has recently announced the successful completion of the Portable Integrated Battlespace Biological Detection Technology (PIBBDT) project. The work, led by manufacturer Biral and funded by the UK Ministry of Defence, involved a consortium of commercial, academic and military specialists with expertise in collector technology, bio-detection and micro-fluidics. These…
More Releases for FMD
FMD Synthetic Peptide Vaccine Market Outlook and Future Projections for 2030
The fmd synthetic peptide vaccine market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
FMD Disease Market 2024 Size, Status and Global Outlook
In recent years, the global FMD Disease Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on FMD Disease Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Cosmetology Insurance Market Is Dazzling Worldwide | PharSafer, FMD K&L, Freyr
HTF Market Intelligence published a new research document of 150+pages on "Cosmetology Insurance Market Insights, to 2030" with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cosmetology Insurance market was mainly driven by the increasing R&D spending by leading and emerging player, however latest scenario and economic slowdown have…
Foot and Mouth Disease (FMD) Vaccines Market Global Outlook Forecast to 2027
The Global Foot and Mouth Disease (FMD) Vaccines Market Report 2021 to 2027 could be a fundamental examination of the global analysis. Trending innovation, advertise drivers, sectional declination, analysis measurements, advertise forecasts, manufacturers, and hardware merchants are all included within the substance. The report incorporates a point-by-point examination of the Foot and Mouth Disease (FMD) Vaccines Market as well as empowering advances, current patterns, openings, and obstruction, as well as…
Global Security Labels Demand Triggered by EU FMD Directive, finds New Study
Safe labeling and packaging are the mega trends triggering demand for security seals and labels, including tamper-evident labels. As regulatory climate and mandates witness growth, security label companies are likely to witness increased orders, especially from the pharmaceutical sector, finds a new Fact.MR study.
The key drivers for security labels include,
Stringent regulatory climate – e.g. EU legislation, Falsified Medicines Directive, mandates higher degree of authentication and tamper verification
Growing emphasis on preventing…
FMD Vaccine Market - Shield against Economic Loss
Foot and Mouth Disease (FMD) causes repetitive outbreak around world thereby causing economic and social damage. Preventing foot and mouth disease is the only sustainable and viable options, which can be done only though the vaccination for FMD, which is expected to drive growth of the foot and mouth disease vaccine market. According to paper published by the Food and Agricultural Organization (FAO) and World Organization for Animal Health (OIE),…